Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

oni global (malaysia) sdn bhd - soy; siberian ginseng root; gotu kola (centella asiatica) extract; ginkgo biloba leaf extract -

Israel - English - Ministry of Health

dr.samuelov importing & marketing ltd, israel - dry extract from ginkgo biloba leaves (35-67:1) - film coated tablets - dry extract from ginkgo biloba leaves (35-67:1) 120 mg - ginkgo biloba - • for the symptomatic treatment of mental losses due to organic brain syndrome within the framework of a general therapeutic concept for dementia syndromes having as major symptoms: deficient memory, disturbances of concentration, depressive mood, dizziness, tinnitus and headache.the primary target group includes patients with demential syndrome in primary degenerative dementia, vascular dementia and mixed forms of both.individual response to the treatment cannot be predicted.note: prior to starting treatment with ginkgo extract, clarification should be obtained as to whether the pathological symptoms encountered are not based on an underlying disease requiring a specific treatment.• vertigo of vascular and involutional origin.• adjuvant treatment in case of tinnitus of vascular and involutional origin.the following note for the patient is included in the instruction leaflet:“frequently occurring dizziness and tinnitus always need to be clarified by a physician. in case of sudden hearing deficit or hearing loss, you should immediately consult a physician.”

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pharma nord sdn. bhd. - ginkgo biloba -

Australia - English - Department of Health (Therapeutic Goods Administration)

careline australia pty ltd - ginkgo biloba -

Australia - English - Department of Health (Therapeutic Goods Administration)

greenfield pharmaceutical pty ltd - ginkgo biloba, quantity: 40 mg (equivalent: ginkgo biloba, qty 2 g) - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; crospovidone; magnesium stearate; colloidal anhydrous silica; hypromellose; macrogol 400; carnauba wax; titanium dioxide - antioxidant/reduce free radicals formed in the body ; maintain/support general health and wellbeing ; maintain/support blood circulation/flow to the peripheral areas of the body (legs, hands and feet) ; maintain/support mental concentration/focus/clarity ; maintain/support cognitive function/mental function ; maintain/support memory/mental recall

Australia - English - Department of Health (Therapeutic Goods Administration)

factors group australia pty ltd - ginkgo biloba, quantity: 60 mg (equivalent: ginkgo biloba, qty 3 g; equivalent: ginkgo flavonglycosides, qty 14.4 mg) - tablet, film coated - excipient ingredients: calcium phosphate; croscarmellose sodium; silicon dioxide; microcrystalline cellulose; magnesium stearate; hypromellose; glycerol - maintain/support blood circulation/flow to the peripheral areas of the body (legs, hands and feet) ; maintain/support mental concentration/focus/clarity ; maintain/support cognitive function/mental function ; enhance/improve/promote/increase mental alertness/wakefulness ; enhance/improve/promote/increase memory/recall ; maintain/support general mental wellbeing

Australia - English - Department of Health (Therapeutic Goods Administration)

vitex pharmaceuticals pty ltd - ginkgo biloba -

Australia - English - Department of Health (Therapeutic Goods Administration)

nature's care manufacture pty limited - ginkgo biloba, quantity: 120 mg (equivalent: ginkgo biloba, qty 6 g; equivalent: ginkgo flavonglycosides, qty 28.8 mg) - capsule, hard - excipient ingredients: gelatin; purified water; colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; calcium hydrogen phosphate dihydrate; povidone - maintain/support general health and wellbeing ; traditionally used in chinese medicine to maintain/support healthy blood circulation ; maintain/support healthy blood circulation ; helps enhance/improve/promote blood circulation to the peripheral areas of the body (legs, hands and feet) ; maintain/support blood circulation/flow to the peripheral areas of the body (legs, hands and feet) ; helps enhance/improve/promote/increase attention span ; maintain/support mental concentration/focus/clarity ; maintain/support cognitive function/mental function ; enhance/improve/promote/increase mental alertness/wakefulness ; enhance/improve/promote/increase memory/recall ; maintain/support memory/mental recall

Australia - English - Department of Health (Therapeutic Goods Administration)

universal pharmaceuticals pty ltd - ginkgo biloba, quantity: 50 mg (equivalent: ginkgo biloba, qty 2.5 g; equivalent: ginkgo flavonglycosides, qty 12 mg) - capsule, soft - excipient ingredients: yellow beeswax; lecithin; iron oxide black; allura red ac; glycerol; titanium dioxide; brilliant blue fcf; sunset yellow fcf; purified water; soya oil; hydrogenated vegetable oil; gelatin - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; traditionally used in chinese medicine to maintain/support healthy blood circulation ; maintain/support healthy blood circulation ; maintain/support cardiovascular system health ; help maintain/support emotional wellbeing ; maintain/support mental concentration/focus/clarity ; maintain/support cognitive function/mental function ; maintain/support memory/mental recall ; maintain/support general mental wellbeing ; maintain/support brain function ; maintain/support brain health

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

american international lab, united states - tablet - 40 mg - ginkgo biloba extracts